Clinical Trial Update: A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment [Phase 2]

View source ↗

Summary

Phase II trial evaluating the combination of docetaxel and oxaliplatin as second-line therapy in advanced non-small cell lung cancer, including squamous and lar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Cell Carcinoma of the Lung
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Korean South West Oncology Group | Conditions: Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous | Phase 2 | Status: UNKNOWN